(WHNT) — The Alabama Department of Public Health issued a statement about its current investigation into certain “adverse events” following an injection. In the news release, ADPH said it is working ...
Postmarketing reports indicate 17 serious adverse events have been reported in vaccine recipients 62 to 89 years old. Due to an ongoing investigation of serious adverse events, it is recommended that ...
On the heels of similar moves in France and the European Union, U.S. health authorities are calling for a pause in the use of Valneva’s chikungunya vaccine in older adults. The FDA and the Centers for ...
Federal drug safety officials have recommended pausing the use of a vaccine for a mosquito-borne disease known as chikungunya for people over 60 following reports of serious adverse events. The Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results